Collegium Pharmaceutical, Inc. (FRA:354)

Collegium Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,302	892	908	729	572	566
Market Cap Growth	43.68%	-1.72%	24.61%	27.51%	0.93%	-7.90%
Enterprise Value	1,861	1,736	1,282	1,288	640	657
Last Close Price	40.60	27.60	27.80	21.40	17.10	16.00
PE Ratio	26.14	13.35	20.84	-	9.09	25.89
PS Ratio	2.02	1.46	1.77	1.68	2.35	2.23
PB Ratio	5.56	4.04	5.14	4.00	3.20	3.72
P/FCF Ratio	5.28	4.54	3.66	6.35	6.40	7.84
P/OCF Ratio	5.25	4.51	3.65	6.27	6.28	7.37
EV/Sales Ratio	2.86	2.85	2.50	2.97	2.63	2.59
EV/EBITDA Ratio	5.34	4.87	4.17	7.99	7.98	6.83
EV/EBIT Ratio	12.37	9.00	7.44	36.13	32.76	14.30
EV/FCF Ratio	7.55	8.84	5.17	11.23	7.16	9.10
Debt / Equity Ratio	3.41	4.28	3.45	3.64	1.27	1.43
Debt / EBITDA Ratio	2.31	2.63	1.96	4.04	2.75	2.21
Debt / FCF Ratio	3.24	4.82	2.46	5.78	2.55	3.02
Asset Turnover	0.47	0.45	0.49	0.50	0.41	0.65
Inventory Turnover	2.35	2.46	2.02	3.70	3.58	5.50
Quick Ratio	1.15	0.77	1.07	0.82	1.05	1.08
Current Ratio	1.36	0.95	1.17	0.97	1.13	1.16
Return on Equity (ROE)	22.96%	32.62%	24.68%	-12.57%	36.77%	19.56%
Return on Assets (ROA)	6.75%	8.89%	10.28%	2.55%	2.08%	7.40%
Return on Capital (ROIC)	8.97%	12.01%	13.43%	3.49%	3.04%	12.52%
Return on Capital Employed (ROCE)	15.20%	17.30%	27.80%	5.10%	5.40%	13.90%
Earnings Yield	3.83%	7.49%	4.80%	-3.21%	11.00%	3.86%
FCF Yield	18.94%	22.01%	27.33%	15.74%	15.63%	12.76%
Buyback Yield / Dilution	13.26%	3.26%	-23.53%	17.58%	-16.77%	-5.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.